Liver Disease

Asia

Gilead Research Scholars Gilead Research Scholars
  • Available Programs
  • Login / Register
Gilead Research Scholars
  • Program Overview
    • Scientific Focus
    • Scientific Review Committee
    • Eligibility
    • Criteria For Selection
  • Application Information
    • Proposal & Budget Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Applications
  • Award Recipients
    • US and Canada
    • Europe and Australia
    • Asia
  • Contact
  • FAQ

Award Recipients

Gilead Sciences Research Scholars Program in Liver Disease

2021 Recipients

Award Recipient Image

Valerie Chew, PhD

Translational Immunology Institute (TII), SingHealth-DukeNUS

Singapore

“Discovery of biomarkers and novel therapeutic strategies for immunotherapy in Hepatocellular carcinoma”

Award Recipient Image

Sadahisa Ogasawara, MD, PhD

Department of Gastroenterology, Graduate School of Medicine Chiba University

Chiba, Japan

“Understandings the mechanism of energy metabolization in intratumor immune microenvironment in metabolic related hepatocellular carcinoma”

Award Recipient Image

Yotaro Kudo, MD, PhD

The Dept. of Gastroenterology, The Graduate School of Medicine, The University of Tokyo

Tokyo, Japan

“The Novel Role of Atypical Protein Kinases C as Key Regulators for Biliary Development, Regeneration, and Tumorigenesis”

2020 Recipients

Award Recipient Image

Hyuk Soo Eun, MD, PhD

Chungham National University Hospital

Daejeon, South Korea

"The major role of NADPH Oxidase 2 – mTORC1 axis in nonalcoholic fatty liver disease-associated hepatocellular carcinoma "

Award Recipient Image

Yuichi Hara, MD

Kawasaki Medical School

Okayama, Japan

"Elucidation of the mechanism underlying iron loss-induced mitophagy and its role in suppression of hepatocellular carcinoma in nonalcoholic steatohepatitis"

Award Recipient Image

Nai Yang Fu, PhD

Duke-NUS Medical School

Singapore

"Exploring the potential of TSPAN8 as a novel biomarker and therapeutic target of hepatocellular carcinoma"

Award Recipient Image

Jung Chen Su, PhD

National Yang Ming University

Taipei, Taiwan

"Identification of Transcription Factor Targets Regulating Multi-Kinases and Acquired Resistance Genes for Drug Development in Hepatocellular Carcinoma”

2019 Recipients

Award Recipient Image

Yun Shen Chan, PhD

Genome Institute of Singapore

Singapore, Singapore

"Unraveling The Molecular Response of NASH Treatment Drugs Using an in Vitro Human Adult Stem Cell Derived Liver Organoid Model"

Award Recipient Image

Hyon- Seung Yi, MD, PhD

Chungnam National University

Daejeon, South Korea

"The Role of Activating Transcription Factor 5-Mediated Mitochondrial Unfolded Protein Response in Fatty Liver Disease"

Award Recipient Image

Thuy Thi Thanh Le, MD, PhD

Osaka City University

Osaka, Japan

"Exploration The Novel Role of Cytoglobin As Therapeutic Approach For Liver Fibrosis And Cancer"

Award Recipient Image

Yuchen Xia, PhD

Wuhan University

Hubei, China

"Dissecting Hepatitis B Virus Covalently Closed Circular DNA"

2018 Recipients

Award Recipient Image

Li-Rung Huang, PhD

National Health Research Institutes

Miaoli County, Taiwan

Development of T-cell Immunotherapy Able to Resist T-cell Exhaustion for Treatment of Hepatocellular Carcinoma

Award Recipient Image

Ruqi Tang, PhD

Shanghai Jiao Tong University

Shanghai, China

Interplay of Host Genetics and Gut Microbiota in Primary Biliary Cholangitis


2018 Recipients (Research Scholars Program in Liver Disease Japan)

Eisuke Murakami, MD, PhD

Hiroshima University Hospital

Hiroshima, Japan

Analysis of molecular mechanisms involved in development of non-alcoholic steatohepatitis

Kazuya Okushin, MD, PhD

The University of Tokyo

Tokyo, Japan

Investigation of a novel mechanism of NASH pathogenesis focused on bile acid transporters, and exploration of a new therapeutic strategy

2017 Recipients

Award Recipient Image

Hye Won Lee, MD, PhD

Yonsei University College of Medicine

Seoul, South Korea

Cell-Free Circulating Tumor DNA as a New Possible Predictive Biomarker in Hepatocellular Carcinoma Development in Asian Patients with Chronic Liver Disease

Award Recipient Image

Sheng-Han Wang, PhD

National Taiwan University College of Medicine

Taipei, Taiwan

Hepatocel/ular Carcinoma in HBV/HCV Dual Infection Patients: How Many are Contributed or Primed by HBV Infection as Revealed by Tumor Integrated HBV DNA Analysis?

2017 Recipients (Research Scholars Program in Liver Disease Japan)

Takahiro Kodama, MD, PhD

Osaka University

Osaka, Japan

Understanding of the novel regulatory mechanism of de-differenciation-mediated hepatocellular carcinoma progression via non-canonical NF-kB and PI3K pathways.

Sayuri Nitta, MD, PhD

Tokyo Medical and Dental University

Tokyo, Japan

Elucidation of the pathophysiological mechanism of HBV in persistent infection and tumorgenesis


2016 Recipients

Award Recipient Image

Young-Sun Lee, MD, PhD

Korea University College of Medicine

Seoul, Korea

Investigating the Roles of CX3CR1 Related with Functional Polarization of Tissue-Resident Macrophages in Alcoholic Liver Disease

Award Recipient Image

Chuanlong Zhu, MD, PhD

The First Affiliated Hospital of Nanjing Medical University

Nanjing, China

Develop Novel Anti-HBV Strategies Based on the Role of EFTUD2 in Innate Immunity

  • US and Canada
  • Europe and Australia
  • Asia

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved. 

Privacy Policy 

Terms of Use 

Funding Considerations